C-C Bond Forming Reactions of C-6 Arylsulfonates
3′,5′-Bis-O-(tert-butyldimethylsilyl)-O6-[(2-nitrophenyl)
sulfonyl]-2′-deoxyguanosine (1b). Yellow powder (48%), Rf
purified by column chromatography on silica gel using CH2-
Cl2 followed by 3% acetone in CH2Cl2.
Characterization data for 2a-d, 2f, 2h, 2i, and 2k have
been described previously,7,9 and data for new compounds are
listed.
1
(10% EtOAc in CH2Cl2) ) 0.51. H NMR: 8.32 (dd, 1H, Ar-
H, J ) 1.0, 7.8), 8.02 (s, 1H, Ar-H), 7.85-7.75 (m, 3H, Ar-
H), 6.29 (t, 1H, 1′, J ) 6.6), 5.03 (br s, 2H, NH2), 4.57 (m, 1H,
3′), 3.98 (app q, 1H, 4′, J ∼ 3.5), 3.80 (dd, 1H, 5′, J ) 3.9, 11.2),
3.74 (dd, 1H, 5′, J ) 3.4, 11.2), 2.54 (app quint, 1H, 2′, J )
5.9, 5.9, 13.2), 2.36 (ddd, 1H, 2′, J ) 3.9, 6.4, 13.2), 0.91, 0.90
2-Amino-6-[4-(phenoxy)phenyl]-9-[3,5-bis-O-(tert-bu-
tyldimethylsilyl)-â-D-erythro-pentofuranosyl]purine (2e).
Pale cream-colored foam, Rf (4% MeOH/16% CH2Cl2/80%
(2s, 18H, SiC(CH3)3), 0.098, 0.074, 0.066 (3s, 12H, SiCH3). 13
C
hexanes) ) 0.29. H NMR: 8.67 (d, 2H, Ar-H, J ) 8.8), 8.05
1
NMR: 158.4, 156.2, 154.0, 148.7, 140.7, 135.1, 132.1, 132.0,
130.8, 124.8, 116.7, 87.9, 84.0, 71.9, 62.8, 41.0, 26.0, 25.8, 18.4,
18.0, -4.7, -4.8, -5.4, -5.5. HRMS calcd for C28H45N6O8SSi2
(M+ + H) 681.2558, found 681.2537.
(s, 1H, Ar-H), 7.38-7.35 (m, 2H, Ar-H), 7.16-7.07 (m, 5H,
Ar-H), 6.40 (t, 1H, 1′, J ) 6.6), 4.98 (br s, 2H, NH2), 4.62 (m,
1H, 3′), 4.01 (app q, 1H, 4′, J ∼ 3.6), 3.82 (dd, 1H, 5′, J ) 4.4,
11.2), 3.77 (dd, 1H, 5′, J ) 3.4, 11.2), 2.65 (ddd, 1H, 2′, J )
5.9, 6.8, 12.7), 2.39 (ddd, 1H, 2′, J ) 3.4, 5.9, 12.7), 0.93, 0.91
(2s, 18H, SiC(CH3)3), 0.12, 0.083, 0.080 (3s, 12H, SiCH3). 13C
NMR: 159.6, 159.4, 156.6, 155.2, 153.9, 139.7, 131.4, 130.8,
129.8, 125.8, 123.7, 119.5, 118.3, 87.8, 83.6, 72.1, 62.9, 40.7,
26.0, 25.8, 18.4, 18.0, -4.7, -4.8, -5.3, -5.5. HRMS calcd for
C34H50N5O4Si2 (M+ + H) 648.3401, found 648.3404.
2-Amino-6-[4-(diphenylamino)phenyl]-9-[3,5-bis-O-(tert-
butyldimethylsilyl)-â-D-erythro-pentofuranosyl]purine
(2g). Yellow foam, Rf (5% EtOAc in CH2Cl2) ) 0.33. 1H NMR:
8.51 (d, 2H, Ar-H, J ) 8.8), 8.02 (s, 1H, Ar-H), 7.29-7.28
(m, 4H, Ar-H), 7.17-7.14 (m, 6H, Ar-H), 7.07 (t, 2H, Ar-H,
J ) 7.5), 6.39 (t, 1H, 1′, J ) 6.6), 4.95 (br s, 2H, NH2), 4.62 (m,
1H, 3′), 4.00 (app q, 1H, 4′, J ∼ 3.6), 3.82 (dd, 1H, 5′, J ) 4.4,
11.2), 3.77 (dd, 1H, 5′, J ) 3.4, 11.2), 2.65 (ddd, 1H, 2′, J )
5.9, 6.8, 13.2), 2.39 (ddd, 1H, 2′, J ) 3.4, 5.9, 13.2), 0.93, 0.91
(2s, 18H, SiC(CH3)3), 0.12, 0.079, 0.076 (3s, 12H, SiCH3). 13C
NMR: 159.4, 155.6, 153.8, 150.1, 147.2, 139.4, 130.6, 129.3,
129.1, 125.7, 125.2, 123.6, 122.0, 87.7, 83.6, 72.1, 62.9, 40.6,
26.0, 25.8, 18.4, 18.0, -4.7, -4.8, -5.3, -5.5. HRMS calcd for
C40H55N6O3Si2 (M+ + H) 723.3874, found 723.3881.
2-Amino-6-[3-(ethoxycarbonyl)phenyl]-9-[3,5-bis-O-(tert-
butyldimethylsilyl )-â-D-erythro-pentofuranosyl]purine
(2j). White foam, Rf (4% MeOH/16% CH2Cl2/80% hexanes) )
0.24. 1H NMR: 9.25 (t, 1H, Ar-H, J ) 1.5), 8.92 (td, 1H, Ar-
H, J ) 1.5, 6.4), 8.15 (td, 1H, Ar-H, J ) 1.5, 7.8), 8.10 (s, 1H,
Ar-H), 7.60 (t, 1H, Ar-H, J ) 7.8), 6.40 (t, 1H, 1′, J ) 6.6),
5.04 (br s, 2H, NH2), 4.63 (m, 1H, 3′), 4.43 (q, 2H, J ) 7.3),
4.01 (app q, 1H, 4′, J ∼ 3.7), 3.83 (dd, 1H, 5′, J ) 4.4, 11.2),
3.77 (dd, 1H, 5′, J ) 3.4, 11.2), 2.65 (ddd, 1H, 2′, J ) 5.9, 6.8,
13.2), 2.40 (ddd, 1H, 2′, J ) 3.4, 5.9, 13.2), 1.43 (t, 3H, CH3, J
) 7.3), 0.93, 0.92 (2s, 18H, SiC(CH3)3), 0.12, 0.088, 0.083 (3s,
12H, SiCH3). 13C NMR: 166.5, 159.5, 154.7, 154.1, 140.2, 136.3,
134.2, 131.4, 130.9, 130.3, 128.5, 126.2, 87.8, 83.6, 72.1, 62.9,
61.1, 40.7, 26.0, 25.8, 18.4, 18.0, 14.4, -4.7, -4.8, -5.4, -5.5.
HRMS calcd for C31H50N5O5Si2 (M+ + H) 628.3351, found
628.3344.
3′,5′-Bis-O-(tert-butyldimethylsilyl)-O6-[(2,4,6-triiso-
propylphenyl)sulfonyl]-2′-deoxyguanosine (1d). White
foam (60%), Rf (10% EtOAc in CH2Cl2) ) 0.51. 1H NMR: 7.97
(s, 1H, Ar-H), 7.19 (s, 2H, Ar-H), 6.29 (t, 1H, 1′, J ) 6.6),
4.85 (br s, 2H, NH2), 4.57 (m, 1H, 3′), 4.31 (sept, 2H, CH, J )
6.7), 3.98 (app q, 1H, 4′, J ∼ 3.3), 3.80 (dd, 1H, 5′, J ) 3.9,
11.2), 3.74 (dd, 1H, 5′, J ) 2.9, 11.2), 2.91 (sept, 1H, CH, J )
6.8), 2.55 (app quint, 1H, 2′, J ) 5.9, 5.9, 13.2), 2.34 (ddd, 1H,
2′, J ) 3.4, 5.9, 13.2), 1.28-1.25 (overlapping d, 18H, (CH3)2),
0.91, 0.89 (2s, 18H, SiC(CH3)3), 0.096, 0.066, 0.054 (3s, 12H,
SiCH3). 13C NMR: 158.4, 155.6, 155.2, 154.2, 150.9, 139.9,
131.5, 123.8, 116.7, 87.9, 83.9, 72.0, 62.8, 40.9, 34.3, 29.8, 25.9,
25.8, 24.6, 23.5, 18.4, 18.0, -4.7, -4.8, -5.4, -5.5. HRMS calcd
for C37H64N5O6SSi2 (M+ + H) 762.4116, found 762.4083.
3′,5′-Bis-O-(tert-butyldimethylsilyl)-O6-[(4-methoxyphe-
nyl)sulfonyl]-2′-deoxyguanosine (1e). White powder (64%),
Rf (10% EtOAc in CH2Cl2) ) 0.32. 1H NMR: 8.08 (d, 2H, Ar-
H, J ) 9.1), 7.99 (s, 1H, Ar-H), 7.01 (d, 2H, Ar-H, J ) 9.1),
6.29 (t, 1H, 1′, J ) 6.6), 4.98 (br s, 2H, NH2), 4.57 (m, 1H, 3′),
3.97 (app q, 1H, 4′, J ∼ 3.4), 3.89 (s, 3H, OCH3), 3.80 (dd, 1H,
5′, J ) 4.4, 11.2), 3.74 (dd, 1H, 5′, J ) 3.4, 11.2), 2.54 (ddd,
1H, 2′, J ) 5.9, 6.8, 13.2), 2.34 (ddd, 1H, 2′, J ) 3.4, 5.9, 13.2),
0.91, 0.89 (2s, 18H, SiC(CH3)3), 0.099, 0.072, 0.064 (3s, 12H,
SiCH3). 13C NMR: 164.5, 158.9, 156.0, 154.8, 140.4, 131.6,
128.3, 117.2, 114.4, 88.1, 84.1, 72.2, 63.0, 56.0, 41.1, 26.2, 26.0,
18.7, 18.2, -4.4, -4.6, -5.2, -5.3. HRMS calcd for C29H48N5O7-
SSi2 (M+ + H) 666.2813, found 666.2821.
3′,5′-Bis-O-(tert-butyldimethylsilyl)-O6-[(2-thienyl)sul-
fonyl]-2′-deoxyguanosine (1f). White powder (62%), Rf (10%
1
EtOAc in CH2Cl2) ) 0.37. H NMR: 8.01 (s, 1H, Ar-H), 7.97
(dd, 1H, Ar-H, J ) 1.5, 3.9), 7.75 (dd, 1H, Ar-H, J ) 1.5,
4.9), 7.14 (dd, 1H, Ar-H, J ) 3.9, 4.9), 6.30 (t, 1H, 1′, J )
6.6), 5.03 (br s, 2H, NH2), 4.57 (m, 1H, 3′), 3.98 (app q, 1H, 4′,
J ∼ 3.4), 3.80 (dd, 1H, 5′, J ) 4.4, 11.2), 3.75 (dd, 1H, 5′, J )
2.9, 11.2), 2.54 (app quint, 1H, 2′, J ) 6.4, 6.4, 13.2), 2.36 (ddd,
1H, 2′, J ) 3.7, 6.4, 13.2), 0.91, 0.90 (2s, 18H, SiC(CH3)3), 0.099,
0.076, 0.068 (3s, 12H, SiCH3). 13C NMR: 158.4, 155.9, 154.3,
140.4, 136.3, 136.1, 135.0, 127.3, 116.8, 87.9, 83.9, 71.9, 62.8,
41.0, 25.9, 25.7, 18.4, 18.0, -4.7, -4.8, -5.4, -5.5. HRMS calcd
for C26H44N5O6S2Si2 (M+ + H) 642.2272, found 642.2286.
Typical Procedure for the Cross Coupling of 1a with
Arylboronic Acids. In an oven-dried, screw-cap vial equipped
with a stir bar were placed Pd(OAc)2 (1.3 mg, 5.8 µmol), L-1
(4.1 mg, 11.7 µmol), K3PO4 (25 mg, 117 µmol), the nucleoside
arylsulfonate 1a (40 mg, 58.9 µmol), and the arylboronic acid
(2 molar equiv). THP or PhMe (0.7 mL) was added, the vial
was flushed with nitrogen and sealed with a Teflon-lined cap,
and the mixture was allowed to stir at room temperature.
Upon completion, the reaction mixture was filtered through
Celite, and the residue was washed with CH2Cl2. Evaporation
of the filtrate provided the crude product mixtures that were
Acknowledgment. Support for this work by NSF
Grant CHE-0314326 and a PSC-CUNY 36 award is
gratefully acknowledged. Acquisition of a 500 MHz
NMR spectrometer was funded by NSF Grant CHE-
0210295. We thank Prof. Kevin Shaughnessy (Univer-
sity of Alabama) for helpful discussions.
Supporting Information Available: Proton NMR spectra
of 1a, 1b, 1d, 1e, 1f, 2e, 2g, and 2j and 31P{1H} NMR spectra
of 1:1 and 2:1 L-1/Pd(OAc)2 complexes obtained at 40 °C. This
material is available free of charge via the Internet at
JO0513764
J. Org. Chem, Vol. 70, No. 25, 2005 10335